Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the Covid-19 Pandemic”
October 2024

A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters
October 2024

A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria
September 2024

Influenza B Virus Receptor Specificity: Closing the Gap between Binding and Tropism
August 2024

Establishment of Swine Primary Nasal, Tracheal, and Bronchial Epithelial Cell Culture Models for the Study of Influenza Virus Infection
June 2024

A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites
May 2024

Pandemic Risk Assessment for Swine Influenza A Virus in Comparative In Vitro and In Vivo Models
March 2024

Swine influenza A virus isolates containing the pandemic H1N1 origin matrix gene elicit greater disease in the murine model
March 2024

A general computational design strategy for stabilizing viral class I fusion proteins
February 2024

Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses
July 2023

Malaria disrupts the rhesus macaque gut microbiome
January 2023

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
December 2022

Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis
November 2022

Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999-2018
January 2022

Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018
January 2022

Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis
May 2021